Pergolide scavenges both hydroxyl and nitric oxide free radicals in vitro and inhibits lipid peroxidation in different regions of the rat brain

Brain Research

Volumn 790, Issue 1-2, 1998, Pages 202-208

  Gómez Vargas, Marvin ^a   Nishibayashi Asanuma, Sakiko ^a   Asanuma, Masato ^a   Kondo, Yoichi ^a   Iwata, Emi ^a   Ogawa, Norio ^a  

^a OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Antioxidant; Dopamine agonist; Electron spin resonance; Free radicals; Lipid peroxidation; Parkinson's disease; Pergolide; Scavenging effect

Indexed keywords

NITRIC OXIDE; PERGOLIDE;

ANIMAL EXPERIMENT; ARTICLE; BRAIN PROTECTION; DOSE RESPONSE; DRUG EFFECT; ELECTRON SPIN RESONANCE; LIPID PEROXIDATION; MALE; NONHUMAN; OXIDATION REDUCTION REACTION; PARKINSON DISEASE; PRIORITY JOURNAL; RAT;

ANIMALS; BENZOATES; BRAIN CHEMISTRY; CORPUS STRIATUM; CYCLIC N-OXIDES; DOPAMINE AGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRON SPIN RESONANCE SPECTROSCOPY; FREE RADICAL SCAVENGERS; GYRUS CINGULI; HYDROXYL RADICAL; IMIDAZOLES; LIPID PEROXIDATION; MALE; NITRIC OXIDE; NUCLEUS ACCUMBENS; OXIDATION-REDUCTION; PERGOLIDE; PHOSPHOLIPIDS; RATS; RATS, SPRAGUE-DAWLEY; SUBSTANTIA NIGRA; TELENCEPHALON;

EID: 0344333478     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(97)01521-7     Document Type: Article

References (33)

1. M. Asanuma, N. Ogawa, S. Nishibayashi, M. Kawai, Y. Kondo, E. Iwata, Protective effects of pergolide on dopamine levels in the 6-hydroxydopamine-lesioned mouse brain, Arch. Int. Pharmacodyn. Ther. 329 (1995) 221-230.
2. J. Beckman, Peroxynitrite versus hydroxyl radical: the role of nitric oxide in superoxide-dependent cerebral injury, in: C.C. Chiueh, D.L. Gilbert, C.A.C. (Eds.), The neurobiology of NO· and OH·, New York Academy of Sciences, New York, 1994, pp. 69-75.
3. G. Benzi, O. Pastoris, F. Marzatico, R.F. Villa, Influence of aging and drug treatment on cerebral glutathione system, Neurobiol. Aging 9 (1988) 371-375.
4. G. Benzi, O. Pastoris, R.F. Villa, Changes induced by aging and drug treatment on cerebral enzymatic antioxidant system, Neurochem. Res. 13 (1988) 467-478.
5. J.A. Buege, S.D. Aust, Microsomal lipid peroxidation, in: S. Fleisher, L. Packer (Eds.), Methods in Enzymology, Vol. 52, Academic Press, New York, 1978, pp. 302-310.
6. M. Carrillo, S. Kanai, M. Nobuku, K. Kitani, (-)Deprenyl induces activities of both superoxide dismutase and catalase but not glutathione peroxidase in the striatum of young male rats, Life Sci. 48 (1991) 517-521.
7. A. Clow, T. Hussain, V. Glover, M. Sandler, M. Walker, D. Dexter, Pergolide can induce superoxide dismutase in rat striata, J. Neural Transm., [GenSect] 90 (1992) 27-31.
8. G. Coppi, Neuroprotective activity of a-dihydroergocriptine in animal models, J. Neural Transm. 45 (1995) 307-317, Suppl.
9. M.L. Cordero, A.E. Negron, J.C. Ortiz, C. Blanco, G. Santiago, Inhibition of high-affinity [3H]L-proline binding to rat brain membranes by 2-amino-7-phosphonoheptanoic acid, Eur. J. Pharmacol. 208 (1991) 179-181.
10. V.L. Dawson, T.M. Dawson, E.D. London, D.S. Bredt, S.H. Snyder, Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures, Proc. Natl. Acad. Sci. U.S.A. 88 (1991) 6368-6371.
11. A. Favit, M.A. Sortino, G. Aleppo, U. Scapagnini, P.L. Canonico, The inhibition of peroxide formation as a possible substrate for the neuroprotective action of dihydroergocryptine, J. Neural Transm. 45 (1995) 297-305, Suppl.
12. D. Feiten, S. Feiten, R. Fuller, T. Romano, E. Smalstig, D. Wong, Chronic dietary pergolide preserves nigrostriatal neuronal integrity in aged-Fischer-344 rats, Neurobiol. Aging 13 (1992) 339-351.
13. M. Gassen, Y. Glinka, B. Pinchasi, M.B.H. Youdim, Apomorphine is a potent free radical scavenger in rat brain mitochondrial fraction, Eur. J. Pharmacol. 308 (1996) 219-225.
14. C.G. Goetz, Dopaminergic agonists in the treatment of Parkinson's disease, in: C.W. Olanow, A.N. Lieberman (Eds.), The Scientific Basis for the Treatment of Parkinson's Disease, Parthenon Publishing Group, Carnforth, UK, 1992, pp. 157-174.
15. A. Gorini, R. Arnaboldi, L. Vercesi, M. Dossena, Influence of some ergot alkaloids on the cerebral reduced glutathione, II Farmaco 11 (1988) 887-890.
16. P. Hantraye, E. Brouillet, R. Ferrante, S. Palfi, R. Dolan, R.T. Matthews, M.F. Beal, Inhibition of neuronal nitric oxide synthase prevents MPTP-induced parkinsonism in baboons, Nature Med. 2 (1996) 1017-1021.
17. S. Hunot, B. Boissière, B. Faucheux, B. Brugg, A. Mouatt-Prigent, Y. Agid, E.C. Hirsch, Nitric oxide synthase and neuronal vulnerability in Parkinson's disease, Neuroscience 72 (1996) 355-363.
18. J. Jankovic, J. Orman, Parallel double-blind study of pergolide in Parkinson's disease, Adv. Neurol. 45 (1986) 551-553.
19. P. Jenner, The rationale for the use of dopamine agonists in Parkinson's disease, Neurology 3 (1995) S6-S12, Suppl.
20. P. Jenner, C.W. Olanow, Oxidative stress and the pathogenesis of Parkinson's disease, Neurology 47 (1996) 161-170.
21. K.W. Lange, W.-D. Rausch, W. Gsell, M. Naumann, E. Oestreicher, P. Riederer, Neuroprotection by dopamine agonists, J. Neural Transm. 43 (1994) 183-201, Suppl.
22. S.A. Lipton, Y.B. Choi, Z.-H. Pan, S.Z. Lei, H.-S.V. Chen, N.J. Sucher, J. Loscalzo, D.J. Singel, J.S. Stamler, A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related niroso-compounds, Nature 364 (1993) 626-632.
23. J.V. Nadler, A. Wang, A. Hakim, Toxicity of L-proline toward rat hippocampal neurons, Brain Res. 456 (1988) 168-172.
24. S. Nishibayashi, M. Asanuma, M. Kohno, M. Gomez-Vargas, N. Ogawa, Scavenging effects of dopamine agonists on nitric oxide radicals, J. Neurochem. 67 (1996) 2208-2211.
25. N. Ogawa, Neuroprotection with dopamine agonists, in: C.W. Olanow, J.A. Obeso (Eds.), Beyond the Decade of the Brain: Dopamine Agonists in Early Parkinson's Disease, Vol. 2, Wells Medical, Kent, 1997, pp. 195-200.
26. N. Ogawa, R. Edamatsu, K. Mizukawa, M. Asanuma, M. Kohno, A. Mori, Degeneration of dopamine neurons and free radicals: possible participation of levodopa, Adv. Neurol. 60 (1993) 242-250.
27. N. Ogawa, K. Tanaka, M. Asanuma, M. Kawai, T. Masumizu, M. Kohno, A. Mori, Bromocriptine protects mice against 6-hydroxydopamine and scavenges hydroxyl free radicals in vitro, Brain Res. 657 (1994) 207-213.
28. S. Przedborski, V. Jackson-Lewis, R. Yokoyama, T. Shibata, V.L. Dawson, T.M. Dawson, Role of nitric oxide in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity, Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 4565-4571.
29. G. Qureshi, S. Baig, I. Bednar, P. Södernsten, G. Forsberg, A. Siden, Increased cerebrospinal fluid concentration of nitrite in Parkinson's disease, NeuroReport 6 (1995) 1642-1644.
30. T. Spencer Smith, W.D.J. Parker, J.P. Bennett, Levodopa increases nigral production of hydroxyl radicals in vivo; potential levodopa toxicity?, NeuroReport 5 (1994) 1009-1011.
31. M.B. Spina, G. Cohen, Dopamine turnover and glutathione oxidation: implications for Parkinson's disease, Proc. Natl. Acad. Sci. U.S.A. 86 (1989) 1398-1400.
32. M. Tanaka, A. Sotomatsu, Y. Toshihiko, S. Hirai, Inhibitory effects of bromocriptine on phospholipid peroxidation induced by DOPA and iron, Neurosci. Lett. 183 (1995) 116-119.
33. T. Yoshikawa, Y. Minamiyama, Y. Naito, M. Kondo, Antioxidant properties of bromocriptine, a dopamine agonist, J. Neurochem. 62 (1994) 1034-1038.